KD-Validated Phosphoglycerate Kinase 1 Mouse Monoclonal Antibody

KD-Validated Phosphoglycerate Kinase 1 Mouse Monoclonal Antibody

Cat. No.: KVAb00812
Size:20μL Price:$118
Size:50μL Price:$218
Size:100μL Price:$318
Application:WB,FCM,ICC,IHC-P

Reactivity:Human,Mouse,Rat
Conjugate:Unconjugated
Gene Name:PGK1
Category: KO&KD Validated Antibodies Tags: , , , , , , , , , , , ,

Summary

Production Name

KD-Validated Phosphoglycerate Kinase 1 Mouse Monoclonal Antibody

Description

KD-Validated antibody

Host

Mouse

Application

WB,FCM,ICC,IHC-P

Reactivity

Human,Mouse,Rat

 

Performance

Conjugation

Unconjugated

Modification

Unmodified

Isotype

Mouse IgG2a kappa

Clonality

Mouse mAb

Form

Liquid

Storage

Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.

Buffer

Supplied in PBS (pH 7.4) containing 50% glycerol, and 0.02% sodium azide.

Purification

Affinity purification

 

Immunogen

Gene Name

PGK1

Alternative Names

PGK1; Phosphoglycerate Kinase 1; Cell Migration-Inducing Gene 10 Protein; Primer Recognition Protein; EC 2.7.2.3; PRP; PGKA; Epididymis Secretory Sperm Binding Protein Li 68p; HEL-S-68p; MIG10

Gene ID

5230

SwissProt ID

P00558

 

Application

Dilution Ratio

WB 1:1,000-1:5,000; FC 1:200-1:2,000; ICC 1:100-1:1,000; IHC-P 1:100-1:200

Molecular Weight

Calculated MW: 44.6kDa

 

Background

The protein encoded by this gene is a glycolytic enzyme that catalyzes the conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate. The encoded protein may also act as a cofactor for polymerase alpha. Additionally, this protein is secreted by tumor cells where it participates in angiogenesis by functioning to reduce disulfide bonds in the serine protease, plasmin, which consequently leads to the release of the tumor blood vessel inhibitor angiostatin. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Deficiency of the enzyme is associated with a wide range of clinical phenotypes hemolytic anemia and neurological impairment. Pseudogenes of this gene have been defined on chromosomes 19, 21 and the X chromosome. [provided by RefSeq, Jan 2014]

 

Research Area

Cardiovascular,Signal Transduction,Cancer,Metabolism

   💬 WhatsApp